ロード中...
Establishment of a patient-derived intrahepatic cholangiocarcinoma xenograft model with KRAS mutation
BACKGROUND: Intrahepatic cholangiocarcinoma (ICC) is an aggressive, highly lethal tumors and lacks of effective chemo and targeted therapies. Cell lines and animal models, even partially reflecting tumor characteristics, have limits to study ICC biology and drug response. In this work, we created an...
保存先:
| 出版年: | BMC Cancer |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4750214/ https://ncbi.nlm.nih.gov/pubmed/26868125 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2136-1 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|